Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott K Johnson

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Scientific American|January 20, 2015
From rain to rangesScott K Johnson
Antimicrobial Agents and Chemotherapy|March 7, 2018
Native Human Monoclonal Antibodies with Potent Cross-Lineage Neutralization of Influenza B VirusesAdam Vigil, Angeles Estélles, Lawrence M Kauvar, et al.
Journal of the American Association for Laboratory Animal Science : JAALAS|September 23, 2016
Comparison of Microchip Transponder and Noncontact Infrared Thermometry with Rectal Thermometry in Domestic Swine (Sus scrofa domestica)Amanda L Jara, Jarod M Hanson, Jon D Gabbard, et al.
Protein Expression and Purification|December 19, 2003
Scale-up of the fermentation and purification of the recombinant heavy chain fragment C of botulinum neurotoxin serotype F, expressed in Pichia pastorisScott K Johnson, Wenhui Zhang, Leonard A Smith, et al.
Science Advances|September 10, 2025
Non-neutralizing antibodies to influenza A matrix-protein-2-ectodomain are broadly effective therapeutics and resistant to viral escape mutationsTeha Kim, Lynn Bimler, Sydney L Ronzulli, et al.
Journal of Virology|September 22, 2017
Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus ChallengeAlaina J Mooney, Jon D Gabbard, Zhuo Li, et al.
Iscience|April 28, 2022
Sex disparities in influenza: A multiscale network analysisChang Wang, Lauren P Lashua, Chalise E Carter, et al.
Journal of Virology|September 27, 2022
Correction for Bimler et al., "Matrix Protein 2 Extracellular Domain-Specific Monoclonal Antibodies Are an Effective and Potentially Universal Treatment for Influenza A"Lynn Bimler, Sydney L Ronzulli, Amber Y Song, et al.
Cell Reports|January 30, 2026
PD-L1 is an intrinsic switch for natural killer cell-mediated, TRAIL-dependent antiviral functionKayla Frank, Himani Sharma, Efthymios Motakis, et al.
Journal of Virology|December 3, 2020
Matrix Protein 2 Extracellular Domain-Specific Monoclonal Antibodies Are an Effective and Potentially Universal Treatment for Influenza ALynn Bimler, Sydney L Ronzulli, Amber Y Song, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Scientific American|January 20, 2015
From rain to rangesScott K Johnson
Antimicrobial Agents and Chemotherapy|March 7, 2018
Native Human Monoclonal Antibodies with Potent Cross-Lineage Neutralization of Influenza B VirusesAdam Vigil, Angeles Estélles, Lawrence M Kauvar, et al.
Journal of the American Association for Laboratory Animal Science : JAALAS|September 23, 2016
Comparison of Microchip Transponder and Noncontact Infrared Thermometry with Rectal Thermometry in Domestic Swine (Sus scrofa domestica)Amanda L Jara, Jarod M Hanson, Jon D Gabbard, et al.
Protein Expression and Purification|December 19, 2003
Scale-up of the fermentation and purification of the recombinant heavy chain fragment C of botulinum neurotoxin serotype F, expressed in Pichia pastorisScott K Johnson, Wenhui Zhang, Leonard A Smith, et al.
Science Advances|September 10, 2025
Non-neutralizing antibodies to influenza A matrix-protein-2-ectodomain are broadly effective therapeutics and resistant to viral escape mutationsTeha Kim, Lynn Bimler, Sydney L Ronzulli, et al.
Journal of Virology|September 22, 2017
Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus ChallengeAlaina J Mooney, Jon D Gabbard, Zhuo Li, et al.
Iscience|April 28, 2022
Sex disparities in influenza: A multiscale network analysisChang Wang, Lauren P Lashua, Chalise E Carter, et al.
Journal of Virology|September 27, 2022
Correction for Bimler et al., "Matrix Protein 2 Extracellular Domain-Specific Monoclonal Antibodies Are an Effective and Potentially Universal Treatment for Influenza A"Lynn Bimler, Sydney L Ronzulli, Amber Y Song, et al.
Cell Reports|January 30, 2026
PD-L1 is an intrinsic switch for natural killer cell-mediated, TRAIL-dependent antiviral functionKayla Frank, Himani Sharma, Efthymios Motakis, et al.
Journal of Virology|December 3, 2020
Matrix Protein 2 Extracellular Domain-Specific Monoclonal Antibodies Are an Effective and Potentially Universal Treatment for Influenza ALynn Bimler, Sydney L Ronzulli, Amber Y Song, et al.
Pageof 3